643 results
Page 10 of 33
8-K
EX-99.1
0a0tkyfyy3lg0n46rl
31 Oct 13
Discovery Labs Prices $50 Million Public Offering of
12:00am
424B5
hyb82v8213huhd8joy8
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K/A
9pai3xos0r6tlb4kr
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.2
zqdom
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
b9p8mpg4qumgrlmz4
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
hvynyp
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
j6h ab1fabnizvpw61m
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K
m5da hmybeiu9db
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K/A
xumvp w3o8l
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K/A
EX-4.1
q0dlpmpge0s5ol
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K
EX-99.1
v24fhmy 0qk4px
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
8-K
t7h69t 3py5e
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
424B5
x6q7e76e9c8
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
2opbo6
7 May 13
Discovery Labs Reports First Quarter 2013 Financial Results
12:00am
8-K
lckjbc
7 May 13
Discovery Labs Reports First Quarter 2013 Financial Results
12:00am
8-K
o4tgwgji
15 Apr 13
Other Events
12:00am